Charles A. Deignan - Net Worth and Insider Trading
Charles A. Deignan Net Worth
The estimated net worth of Charles A. Deignan is at least $473,134 dollars as of 2024-06-10. Charles A. Deignan is the CFO of Clearside Biomedical Inc and owns about 384,662 shares of Clearside Biomedical Inc (CLSD) stock worth over $473,134. Details can be seen in Charles A. Deignan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Charles A. Deignan has not made any transactions after 2024-01-19 and currently still holds the listed stock(s).
Transaction Summary of Charles A. Deignan
Charles A. Deignan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles A. Deignan owns 1 companies in total, including Clearside Biomedical Inc (CLSD) .
Click here to see the complete history of Charles A. Deignan’s form 4 insider trades.
Insider Ownership Summary of Charles A. Deignan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CLSD | Clearside Biomedical Inc | 2024-01-19 | Chief Financial Officer |
Charles A. Deignan Latest Holdings Summary
Charles A. Deignan currently owns a total of 1 stock. Charles A. Deignan owns 384,662 shares of Clearside Biomedical Inc (CLSD) as of January 19, 2024, with a value of $473,134.
Latest Holdings of Charles A. Deignan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CLSD | Clearside Biomedical Inc | 2024-01-19 | 384,662 | 1.23 | 473,134 |
Holding Weightings of Charles A. Deignan
Charles A. Deignan Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles A. Deignan has made a total of 7 transactions in Clearside Biomedical Inc (CLSD) over the past 5 years, including 1 buys and 6 sells. The most-recent trade in Clearside Biomedical Inc is the sale of 12,900 shares on January 19, 2024, which brought Charles A. Deignan around $16,512.
Insider Trading History of Charles A. Deignan
- 1
Charles A. Deignan Trading Performance
GuruFocus tracks the stock performance after each of Charles A. Deignan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles A. Deignan is 31.17%. GuruFocus also compares Charles A. Deignan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles A. Deignan within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Charles A. Deignan's insider trading performs compared to the benchmark.
Performance of Charles A. Deignan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.61 | | | | | |
| Relative Return to S&P 500(%) | 10.16 | | | | | |
Charles A. Deignan Ownership Network
Charles A. Deignan Owned Company Details
What does Clearside Biomedical Inc do?
Who are the key executives at Clearside Biomedical Inc?
Charles A. Deignan is the Chief Financial Officer of Clearside Biomedical Inc. Other key executives at Clearside Biomedical Inc include 10 percent owner Bradford T Whitmore , director & 10 percent owner Clay Thorp , and Chief Medical Officer Thomas Ciulla .
Clearside Biomedical Inc (CLSD) Insider Trades Summary
Over the past 18 months, Charles A. Deignan made 2 insider transaction in Clearside Biomedical Inc (CLSD) with a net sale of 26,930. Other recent insider transactions involving Clearside Biomedical Inc (CLSD) include a net purchase of 580,222 shares made by Bradford T Whitmore , a net sale of 38,030 shares made by George M Lasezkay , and a net purchase of 24,000 shares made by Clay Thorp .
In summary, during the past 3 months, insiders sold 0 shares of Clearside Biomedical Inc (CLSD) in total and bought 137,813 shares, with a net purchase of 137,813 shares. During the past 18 months, 80,830 shares of Clearside Biomedical Inc (CLSD) were sold and 752,035 shares were bought by its insiders, resulting in a net purchase of 671,205 shares.
Clearside Biomedical Inc (CLSD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Clearside Biomedical Inc Insider Transactions
Charles A. Deignan Mailing Address
Above is the net worth, insider trading, and ownership report for Charles A. Deignan. You might contact Charles A. Deignan via mailing address: C/o Clearside Biomedical, Inc., 1220 Old Alpharetta Road, Suite 300, Alpharetta Ga 30005.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
